CNS relapse in the brain parenchyma, eyes, or leptomeninges is an uncommon but devastating complication of diffuse large B-cell lymphoma. CNS prophylaxis strategies, typically involving intrathecal or high-dose antimetabolites, have been developed in the front-line treatment setting with the aim to reduce this subsequent risk. Clinical and biological features associated with elevated risk are increasingly well defined and are discussed in this Review. This Review summarises both the historical and current developments in this challenging field, provides a nuanced discussion regarding current reasons for and against standard prophylactic measures, outlines evidence for the timing of prophylactic measures when delivered, and reflects on possible future developments.

CNS prophylaxis for diffuse large B-cell lymphoma / Eyre, T. A.; Savage, K. J.; Cheah, C. Y.; El-Galaly, T. C.; Lewis, K. L.; Mckay, P.; Wilson, M. R.; Evens, A. M.; Bobillo, S.; Villa, D.; Maurer, M. J.; Cwynarski, K.; Ferreri, A. J. M.. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - 23:9(2022), pp. 416-426. [10.1016/S1470-2045(22)00371-0]

CNS prophylaxis for diffuse large B-cell lymphoma

Ferreri A. J. M.
Ultimo
2022-01-01

Abstract

CNS relapse in the brain parenchyma, eyes, or leptomeninges is an uncommon but devastating complication of diffuse large B-cell lymphoma. CNS prophylaxis strategies, typically involving intrathecal or high-dose antimetabolites, have been developed in the front-line treatment setting with the aim to reduce this subsequent risk. Clinical and biological features associated with elevated risk are increasingly well defined and are discussed in this Review. This Review summarises both the historical and current developments in this challenging field, provides a nuanced discussion regarding current reasons for and against standard prophylactic measures, outlines evidence for the timing of prophylactic measures when delivered, and reflects on possible future developments.
2022
Inglese
Elsevier Ltd
23
9
416
426
11
Pubblicato
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(22)00371-0/fulltext
Esperti anonimi
Internazionale
Goal 3: Good health and well-being
CNS prophylaxis for diffuse large B-cell lymphoma / Eyre, T. A.; Savage, K. J.; Cheah, C. Y.; El-Galaly, T. C.; Lewis, K. L.; Mckay, P.; Wilson, M. R.; Evens, A. M.; Bobillo, S.; Villa, D.; Maurer, M. J.; Cwynarski, K.; Ferreri, A. J. M.. - In: THE LANCET ONCOLOGY. - ISSN 1470-2045. - 23:9(2022), pp. 416-426. [10.1016/S1470-2045(22)00371-0]
none
13
info:eu-repo/semantics/article
262
Eyre, T. A.; Savage, K. J.; Cheah, C. Y.; El-Galaly, T. C.; Lewis, K. L.; Mckay, P.; Wilson, M. R.; Evens, A. M.; Bobillo, S.; Villa, D.; Maurer, M. J...espandi
1 Contributo su Rivista::1.1.1 Articolo in rivista - Review
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/153361
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 27
social impact